Compare this test’s laboratory options
Pharmacogenomics Panel
Quest Diagnostics1 test optionFrom $699.30
Pharmacogenomics Panel
Quest DiagnosticsWhat this laboratory test evaluates
DetailsGenetics can play a significant role in the selection of certain medications. For instance, individuals may metabolize medications too fast or too slow. This test analyzes genes of known pharmacogenomic value allowing clinicians to gain valuable insight into an individual's response to and adverse effects from medications with known gene-drug interactions. In partnership with Coriell Life Sciences, this test offers an enhanced report providing medication guidance and clinical annotation based on the genetic results provided by Quest Diagnostics.
Test ResourcesTest FAQ: Pharmacogenomics Panel
Additional test information
Genetics can play a significant role in the selection of certain medications. For instance, individuals may metabolize medications too fast or too slow. This test analyzes genes of known pharmacogenomic value allowing clinicians to gain valuable insight into an individual's response to and adverse effects from medications with known gene-drug interactions.
Collection and processing
- Sample type: Whole blood
- Fasting: No
- Estimated laboratory processing: Results should be available in 2 – 5 business days after the sample is collected
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
About this test
DetailsGenetics can play a significant role in the selection of certain medications. For instance, individuals may metabolize medications too fast or too slow. This test analyzes genes of known pharmacogenomic value allowing clinicians to gain valuable insight into an individual's response to and adverse effects from medications with known gene-drug interactions. In partnership with Coriell Life Sciences, this test offers an enhanced report providing medication guidance and clinical annotation based on the genetic results provided by Quest Diagnostics.
Test ResourcesTest FAQ: Pharmacogenomics Panel
Additional details
Genetics can play a significant role in the selection of certain medications. For instance, individuals may metabolize medications too fast or too slow. This test analyzes genes of known pharmacogenomic value allowing clinicians to gain valuable insight into an individual's response to and adverse effects from medications with known gene-drug interactions.
Highlighted health areas
- Genetics
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- Factor V (F5), DNA Analysis
- SLCO1B1 Mutation Analysis
- ABCG2 Genotype
- ABCG2 Phenotype
- CYP2B6 Genotype
- CYP2B6 Phenotype
- CYP2C9 Genotype
- CYP2C9 Phenotype
- CYP2C19 Genotype
- CYP2C19 Phenotype
- CYP2D6 Genotype
- CYP2D6 Phenotype
- CYP3A4 Genotype
- CYP3A4 Phenotype
- CYP3A5 Genotype
- CYP3A5 Phenotype
- CYP4F2 Genotype
- CYP4F2 Phenotype
- DPYD Mutation Analysis
- DPYD Phenotype
- F5 Phenotype
- HLA A*31:01 Genotype
- HLA A*31:01 Phenotype
- HLA B*15:02 Genotype
- HLA B*15:02 Phenotype
- HLA B*57:01 Genotype
- HLA B*57:01 Phenotype
- HLA B*58:01 Genotype
- HLA B*58:01 Phenotype
- IFNL3 Genotype
View all 42 listed biomarkers
- IFNL3 Phenotype
- NAT2 Genotype
- NAT2 Phenotype
- NUDT15 Mutation Analysis
- NUDT15 Phenotype
- SLCO1B1 Phenotype
- TPMT Mutation Analysis
- TPMT Phenotype
- UGT1A1 Genotype
- UGT1A1 Phenotype
- VKORC1 Genotype
- VKORC1 Phenotype